Celanese Q2 2025 GAAP EPS $1.90, adjusted EPS $1.44; guides Q3 adj. EPS $1.10-$1.40

Celanese Corp

2025-Q2 EPS reported $1.62 revenue$4,921,000,000

Net sales $2.5B (+6% QoQ); operating profit $233M; adjusted EBIT $344M; operating EBITDA $532M.
Engineered Materials net sales $1.44B (+12% QoQ), adjusted EBIT $214M; Acetyl Chain net sales $1.12B, adjusted EBIT $196M.
Free cash flow $311M (vs -$73M prior Q); repaid $200M term loan; new $1.75B revolver through 2030.
Expects ~$25M negative earnings impact from inventory reduction; targeting $700-$800M free cash flow in 2025.
Announced exit of Sempach Elotex site and Sarnia Vamac site; Micromax divestiture to second round.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.